Literature DB >> 11782602

Dysplasia of the gut: the diagnosis is harder than it seems.

Barbara J McKenna1, Henry D Appelman.   

Abstract

Preneoplastic epithelia of the gut have been given several different names, but the one most often used is dysplasia. Dysplasias of the gut are diagnosed by pathologists, using a set of cytologic and architectural features, and are divided into two grades: low- and high-grade. Although the definitions imply that all low-grade dysplasias are similar (as are all high-grades), in reality, there is significant heterogeneity in the appearances of each grade of dysplasia. Thus, separating low-from high-grade epithelium may be difficult. In addition, the features that characterize low-grade epithelia are very similar to many examples of epithelial regeneration, and so these may not be readily separable. Such cases may be classified as being indefinite for dysplasia. For these reasons, and because the implications for patient care are significant, the interpretations of biopsies taken for dysplasia surveillance are considered challenging by most pathologists. Clinicians must understand the challenging nature of these biopsies, communicate with the pathologists who will interpret such biopsies, and obtain an adequate sample of the mucosa to ensure that dysplasia, if present, will be biopsied and appropriately diagnosed.

Entities:  

Mesh:

Year:  2002        PMID: 11782602     DOI: 10.1097/00004836-200202000-00002

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

Review 1.  Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Authors:  Sachin Wani; V Raman Muthusamy; Nicholas J Shaheen; Rena Yadlapati; Robert Wilson; Julian A Abrams; Jacques Bergman; Amitabh Chak; Kenneth Chang; Ananya Das; John Dumot; Steven A Edmundowicz; Glenn Eisen; Gary W Falk; M Brian Fennerty; Lauren Gerson; Gregory G Ginsberg; David Grande; Matt Hall; Ben Harnke; John Inadomi; Janusz Jankowski; Charles J Lightdale; Jitin Makker; Robert D Odze; Oliver Pech; Richard E Sampliner; Stuart Spechler; George Triadafilopoulos; Michael B Wallace; Kenneth Wang; Irving Waxman; Srinadh Komanduri
Journal:  Am J Gastroenterol       Date:  2017-06-01       Impact factor: 10.864

Review 2.  Quality Indicators in Endoscopic Ablation for Barrett's Esophagus.

Authors:  Samuel Han; Sachin Wani
Journal:  Curr Treat Options Gastroenterol       Date:  2017-06

3.  Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis.

Authors:  David R Martin; David R Braxton; Alton B Farris
Journal:  Virchows Arch       Date:  2016-08-05       Impact factor: 4.064

Review 4.  In vivo cancer biomarkers of esophageal neoplasia.

Authors:  Shaoying Lu; Thomas D Wang
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.